Format

Send to

Choose Destination
Vaccine. 2009 Jun 24;27 Suppl 2:B42-50. doi: 10.1016/j.vaccine.2009.05.001. Epub 2009 May 28.

Meningococcal protein antigens and vaccines.

Author information

1
Division of Bacteriology, National Institute for Biological Standards and Control, Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN6 3QG, United Kingdom. ian.feavers@nibsc.hpa.org.uk

Abstract

The development of a comprehensive vaccine against meningococcal disease has been challenging. Recent developments in molecular genetics have provided both explanations for these challenges and possible solutions. Since genome sequence data became available there has been a marked increase in number of protein antigens that have been suggested as prospective vaccine components. This review catalogues the proposed vaccine candidates and examines the evidence for their inclusion in potential protein vaccine formulations.

PMID:
19481315
DOI:
10.1016/j.vaccine.2009.05.001
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center